Alaunos Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Alaunos Therapeutics, Inc. (TCRT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $56.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-14
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $56.00K, a 22.22% decline year-over-year.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $56.00K, a 17.65% decline year-over-year.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $35.00K, a 56.79% decline year-over-year.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $239.00K, a 198.75% increase year-over-year.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $414.00K, a 4.83% decline from fiscal 2024.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $435.00K, a 84.46% decline from fiscal 2023.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $2.80M, a 20.63% decline from fiscal 2022.
- Alaunos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.53M, a 67.25% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $56.00K 10-Q · filed 2026-08-14 | $113.00K 10-Q · filed 2026-08-14 | $147.00K derived: sum of 3 quarters · filed 2026-08-14 | $386.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-15 | $91.00K derived: sum of 2 quarters · filed 2026-05-15 | $330.00K derived: sum of 3 quarters · filed 2026-05-15 | $402.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $274.00K derived: sum of 2 quarters · filed 2026-03-31 | $346.00K derived: sum of 3 quarters · filed 2026-08-14 | $414.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $239.00K 10-Q · filed 2025-11-14 | $311.00K derived: sum of 2 quarters · filed 2026-08-14 | $379.00K 10-Q · filed 2025-11-14 | $460.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $72.00K 10-Q · filed 2026-08-14 | $140.00K 10-Q · filed 2025-08-14 | $221.00K derived: sum of 3 quarters · filed 2026-08-14 | $301.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $68.00K 10-Q · filed 2026-05-15 | $149.00K derived: sum of 2 quarters · filed 2026-05-15 | $229.00K derived: sum of 3 quarters · filed 2026-05-15 | $331.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $161.00K derived: sum of 2 quarters · filed 2026-03-31 | $263.00K derived: sum of 3 quarters · filed 2026-03-31 | $435.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $80.00K 10-Q · filed 2025-11-14 | $182.00K derived: sum of 2 quarters · filed 2025-11-14 | $354.00K 10-Q · filed 2025-11-14 | $604.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $102.00K 10-Q · filed 2025-08-14 | $274.00K 10-Q · filed 2025-08-14 | $524.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.25M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $172.00K 10-Q · filed 2025-05-15 | $422.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.15M derived: sum of 3 quarters · filed 2025-05-15 | $2.06M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $976.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.89M derived: sum of 3 quarters · filed 2025-03-31 | $2.80M 10-K · filed 2025-03-31 |
| 2023-09-30 | $726.00K 10-Q · filed 2024-11-14 | $1.64M derived: sum of 2 quarters · filed 2024-11-14 | $2.55M 10-Q · filed 2024-11-14 | $3.43M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $914.00K 10-Q · filed 2024-08-14 | $1.82M 10-Q · filed 2024-08-14 | $2.70M derived: sum of 3 quarters · filed 2024-08-14 | $3.51M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $910.00K 10-Q · filed 2024-05-15 | $1.79M derived: sum of 2 quarters · filed 2024-05-15 | $2.60M derived: sum of 3 quarters · filed 2024-05-15 | $3.58M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.69M derived: sum of 2 quarters · filed 2024-04-01 | $2.67M derived: sum of 3 quarters · filed 2024-04-01 | $3.53M 10-K · filed 2024-04-01 |
| 2022-09-30 | $808.00K 10-Q · filed 2023-11-14 | $1.80M derived: sum of 2 quarters · filed 2023-11-14 | $2.65M 10-Q · filed 2023-11-14 | $3.57M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $990.00K 10-Q · filed 2023-08-14 | $1.84M 10-Q · filed 2023-08-14 | $2.76M derived: sum of 3 quarters · filed 2023-08-14 | $5.13M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $853.00K 10-Q · filed 2023-05-10 | $1.77M derived: sum of 2 quarters · filed 2023-05-10 | $4.14M derived: sum of 3 quarters · filed 2023-05-10 | $9.43M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $3.29M derived: sum of 2 quarters · filed 2023-03-07 | $8.58M derived: sum of 3 quarters · filed 2023-03-07 | $10.77M 10-K · filed 2023-03-07 |
| 2021-09-30 | $2.37M 10-Q · filed 2022-11-14 | $7.66M derived: sum of 2 quarters · filed 2022-11-14 | $9.86M 10-Q · filed 2022-11-14 | $11.29M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $5.29M 10-Q · filed 2022-08-15 | $7.49M 10-Q · filed 2022-08-15 | $8.92M derived: sum of 3 quarters · filed 2022-08-15 | $10.71M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.20M 10-Q · filed 2022-05-16 | $3.63M derived: sum of 2 quarters · filed 2022-05-16 | $5.42M derived: sum of 3 quarters · filed 2022-05-16 | $7.09M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.23M derived: sum of 2 quarters · filed 2022-03-30 | $4.89M derived: sum of 3 quarters · filed 2022-03-30 | $6.83M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.79M 10-Q · filed 2021-11-08 | $3.45M derived: sum of 2 quarters · filed 2021-11-08 | $5.39M 10-Q · filed 2021-11-08 | $6.99M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $1.66M 10-Q · filed 2021-08-13 | $3.60M 10-Q · filed 2021-08-13 | $5.20M derived: sum of 3 quarters · filed 2021-08-13 | $6.69M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $1.94M 10-Q · filed 2021-05-06 | $3.54M derived: sum of 2 quarters · filed 2021-05-06 | $5.03M derived: sum of 3 quarters · filed 2021-05-06 | $6.83M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.09M derived: sum of 2 quarters · filed 2021-03-01 | $4.88M derived: sum of 3 quarters · filed 2021-03-01 | $6.34M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.49M 10-Q · filed 2020-11-05 | $3.29M derived: sum of 2 quarters · filed 2020-11-05 | $4.74M 10-Q · filed 2020-11-05 | $5.42M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.80M 10-Q · filed 2020-08-06 | $3.25M 10-Q · filed 2020-08-06 | $3.94M derived: sum of 3 quarters · filed 2021-03-01 | $5.42M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.46M 10-Q · filed 2020-05-07 | $2.14M derived: sum of 2 quarters · filed 2021-03-01 | $3.62M derived: sum of 3 quarters · filed 2021-03-01 | $5.33M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.16M derived: sum of 2 quarters · filed 2021-03-01 | $3.88M derived: sum of 3 quarters · filed 2021-03-01 | $7.53M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.48M 10-Q · filed 2019-11-07 | $3.19M derived: sum of 2 quarters · filed 2019-11-07 | $6.85M 10-Q · filed 2019-11-07 | $9.14M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.71M 10-Q · filed 2019-08-08 | $5.37M 10-Q · filed 2019-08-08 | $7.66M derived: sum of 3 quarters · filed 2020-03-02 | $9.74M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $3.66M 10-Q · filed 2019-05-08 | $5.95M derived: sum of 2 quarters · filed 2020-03-02 | $8.03M derived: sum of 3 quarters · filed 2020-03-02 | $10.09M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.37M derived: sum of 2 quarters · filed 2020-03-02 | $6.43M derived: sum of 3 quarters · filed 2020-03-02 | $8.45M 10-K · filed 2020-03-02 |
| 2017-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $4.14M derived: sum of 2 quarters · filed 2017-11-06 | $6.17M 10-Q · filed 2017-11-06 | $8.52M derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $4.08M 10-Q · filed 2017-07-31 | $6.44M derived: sum of 3 quarters · filed 2019-03-05 | $8.46M derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-03-31 | $2.02M 10-Q · filed 2017-05-01 | $4.38M derived: sum of 2 quarters · filed 2019-03-05 | $6.40M derived: sum of 3 quarters · filed 2019-03-05 | $8.47M derived: sum of 4 quarters · filed 2019-03-05 |
| 2016-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $4.38M derived: sum of 2 quarters · filed 2019-03-05 | $6.44M derived: sum of 3 quarters · filed 2019-03-05 | $8.45M 10-K · filed 2019-03-05 |
| 2016-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.08M derived: sum of 2 quarters · filed 2016-11-09 | $6.09M 10-Q · filed 2016-11-09 | $8.04M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.08M 10-Q · filed 2016-08-09 | $6.02M derived: sum of 3 quarters · filed 2018-03-01 | $7.50M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $2.01M 10-Q · filed 2016-05-10 | $3.95M derived: sum of 2 quarters · filed 2018-03-01 | $5.43M derived: sum of 3 quarters · filed 2018-03-01 | $8.91M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.42M derived: sum of 2 quarters · filed 2018-03-01 | $6.90M derived: sum of 3 quarters · filed 2018-03-01 | $8.00M 10-K · filed 2018-03-01 |
| 2015-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $4.96M derived: sum of 2 quarters · filed 2015-11-02 | $6.05M 10-Q · filed 2015-11-02 | $7.21M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $4.58M 10-Q · filed 2015-08-10 | $5.74M derived: sum of 3 quarters · filed 2017-02-16 | $6.88M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | $1.09M 10-Q · filed 2015-05-07 | $2.25M derived: sum of 2 quarters · filed 2017-02-16 | $3.40M derived: sum of 3 quarters · filed 2017-02-16 | $4.61M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $2.31M derived: sum of 2 quarters · filed 2017-02-16 | $3.52M derived: sum of 3 quarters · filed 2017-02-16 | $4.74M 10-K · filed 2017-02-16 |
| 2014-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $2.36M derived: sum of 2 quarters · filed 2014-10-30 | $3.58M 10-Q · filed 2014-10-30 | $4.61M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.44M 10-Q · filed 2014-08-07 | $3.46M derived: sum of 3 quarters · filed 2016-02-24 | $4.27M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $1.22M 10-Q · filed 2014-05-08 | $2.25M derived: sum of 2 quarters · filed 2016-02-24 | $3.06M derived: sum of 3 quarters · filed 2016-02-24 | $3.19M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $1.83M derived: sum of 2 quarters · filed 2016-02-24 | $1.97M derived: sum of 3 quarters · filed 2016-02-24 | $3.51M 10-K · filed 2016-02-24 |
| 2013-09-30 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $941.00K derived: sum of 2 quarters · filed 2013-10-22 | $2.48M 10-Q · filed 2013-10-22 | $3.88M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.67M 10-Q · filed 2013-08-08 | $3.07M derived: sum of 3 quarters · filed 2015-02-26 | $4.26M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $1.54M 10-Q · filed 2013-05-07 | $2.94M derived: sum of 2 quarters · filed 2015-02-26 | $4.13M derived: sum of 3 quarters · filed 2015-02-26 | $5.21M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $2.59M derived: sum of 2 quarters · filed 2015-02-26 | $3.67M derived: sum of 3 quarters · filed 2015-02-26 | $4.88M 10-K · filed 2015-02-26 |
| 2012-09-30 | $1.19M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | $2.27M derived: sum of 2 quarters · filed 2012-11-08 | $3.48M 10-Q · filed 2012-11-08 | $4.34M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $1.08M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28 | $2.29M 10-Q/A · filed 2012-08-28 | $3.15M derived: sum of 3 quarters · filed 2014-03-03 | $3.73M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $1.21M 10-Q · filed 2012-05-03 | $2.07M derived: sum of 2 quarters · filed 2014-03-03 | $2.66M derived: sum of 3 quarters · filed 2014-03-03 | |
| 2011-12-31 | $859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.45M derived: sum of 2 quarters · filed 2014-03-03 | $2.76M 10-K · filed 2014-03-03 | |
| 2011-09-30 | $586.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-03 | $1.90M 10-Q · filed 2011-11-03 | ||
| 2011-06-30 | $1.31M 10-Q/A · filed 2011-08-09 | |||
| 2010-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $3.64M 10-K · filed 2014-03-03 | ||
| 2010-09-30 | $3.20M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $2.18M 10-K · filed 2014-03-03 | |||
| 2008-12-31 | $1.60M 10-K · filed 2014-03-03 | |||
| 2006-12-31 | $2.78M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |